Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Frontage Laboratories

Frontage Laboratories?uq=oeHSfu7P
2001 FOUNDED
M&A STATUS
601-700 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
5 INVESTMENTS
Description

Provider of research & development support to biopharmaceutical organizations. The company offers bio analysis, preclinical, clinical studies, analytical testing, product development support, spanning discovery stages through late stage clinical trials. It also provides turnkey product development, bio equivalence, analytical services to generic and consumer health pharmaceutical companies to support abbreviated new drug application.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Primary Office
  • 700 Pennsylvania Drive
  • Exton, PA 19341
  • United States

+1 (610) 000-0000

Frontage Laboratories Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Frontage Laboratories‘s full profile, request access.

Request full access to PitchBook

Frontage Laboratories Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 30-Mar-2018 000000000000000000 Drug Discovery 0000 00 00.0
000 00000000000000 04-Jun-2016 000000000 00000 00 Buildings and Property 0000 00 00.0
00000000-000 15-Jul-2015 000000000 Enterprise Systems (Healthcare) 0000 00 00.0
00000000 000000000 24-Jun-2008 0000000000 Biotechnology 0000 00 00.0
Advanced Biomedical Research 15-Jun-2007 Corporate Biotechnology 0000 00 00.0
To view this company’s complete investment and acquisition history, request access »

Frontage Laboratories Subsidiaries (1)

Company Name Industry Location Founded
0000000 0000000000 Drug Discovery Concord, OH 0000
To view this company’s complete subsidiary history, request access »

Frontage Laboratories Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Frontage Laboratories‘s full profile, request access.

Request full access to PitchBook

Frontage Laboratories Executive Team (5)

Name Title Board
Seat
Contact
Info
Song Li Ph.D Founder & Chief Executive Officer
Michael Willett President, Clinical Services
Abdul Mutlib Ph.D Executive Vice President of Drug Metabolism and Pharmacokinetics & Clinical Trials lead
Wendy Nelson Vice President of Business Development, Marketing and Strategic Alliance

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »